CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Purchase | +600,309 | $44.00 | $26.4M | 6,117,295 |
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Purchase · Prefunded Warrants | +55,191 | $44.00 | $2.4M | 974,192 |
| 2025-06-30 | BAKER BROS. ADVISORS LP Director | Purchase · Prefunded Warrants | +600,309 | $44.00 | $26.4M | 10,225,962 |
| 2025-06-25 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-25 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Albers Jeffrey W. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Hrustanovic Gorjan Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Esposito Pamela Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Sandor Victor Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-25 | Ridloff Elena Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-11 | Ridloff Elena Director | Option exercise 10b5-1 | +4,500 | $20.29 | $91K | 4,500 |
| 2025-06-11 | Ridloff Elena Director | Sale 10b5-1 | −4,500 | $50.00 | $225K | 0 |
| 2025-06-11 | Ridloff Elena Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,500 | 4,500 | ||
| 2025-06-03 | Esposito Pamela Director | Option exercise 10b5-1 | +5,000 | $29.55 | $148K | 5,000 |
| 2025-06-03 | Esposito Pamela Director | Sale 10b5-1 | −5,000 | $49.04 | $245K | 0 |
| 2025-06-03 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 24,127 | ||
| 2025-06-03 | Ridloff Elena Director | Option exercise 10b5-1 | +12,000 | $27.67 | $332K | 12,000 |
Page 22 of 25 · 493 trades